These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6674474)

  • 1. Sustained release of drugs by inclusion in plastic matrices. I. Dexchlorpheniramine maleate.
    Alfonso Zerquera HM; Bermudez Benitez E; De Armas Leyva R
    J Pharm Belg; 1983; 38(6):315-9. PubMed ID: 6674474
    [No Abstract]   [Full Text] [Related]  

  • 2. Floating hot-melt extruded tablets for gastroretentive controlled drug release system.
    Fukuda M; Peppas NA; McGinity JW
    J Control Release; 2006 Oct; 115(2):121-9. PubMed ID: 16959356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of sustained release hot-melt extruded tablets containing chitosan and xanthan gum.
    Fukuda M; Peppas NA; McGinity JW
    Int J Pharm; 2006 Mar; 310(1-2):90-100. PubMed ID: 16413153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sensitivity of cationic polymer Eudragit RL to electrolytes and its effect on drug release from Eudragit RL matrix].
    Fu C; Zhao L; Jiang X
    Yao Xue Xue Bao; 1998 Jul; 33(7):538-43. PubMed ID: 12016889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained-release dosage forms containing chlorpheniramine maleate with water-insoluble glucan.
    Masumoto K; Matsumoto K; Yoshida A; Hayashi S; Nambu N; Nagai T
    Chem Pharm Bull (Tokyo); 1984 Mar; 32(3):1055-62. PubMed ID: 6744480
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro dissolution profile and in vivo absorption study of sustained-release tablets containing chlorpheniramine maleate with water-insoluble glucan.
    Masumoto K; Matsumoto K; Yoshida A; Hayashi S; Nambu N; Nagai T
    Chem Pharm Bull (Tokyo); 1984 Sep; 32(9):3720-3. PubMed ID: 6525661
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sustained-release tablets: predominant mechanism of release of a tracer from matrices composed of total and partial glycerides].
    Doelker C; Doelker E
    Pharm Acta Helv; 1982; 57(7):189-92. PubMed ID: 7122647
    [No Abstract]   [Full Text] [Related]  

  • 10. Drugs acting as plasticizers in polymeric systems: a quantitative treatment.
    Siepmann F; Le Brun V; Siepmann J
    J Control Release; 2006 Oct; 115(3):298-306. PubMed ID: 17045358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formula optimization based on neural networksin sustained release tablets.
    Wei X; Liang W
    Pharmazie; 2003 Jul; 58(7):521-2. PubMed ID: 12889541
    [No Abstract]   [Full Text] [Related]  

  • 12. Eudragit matrices for sustained release of ketorolac tromethamine: formulation and kinetics of release.
    Ruckmani K; Muneera MS; Vijaya R
    Boll Chim Farm; 2000; 139(5):205-8. PubMed ID: 11213438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation optimization of sustained-release tablet of chlorpheniramine maleate by means of extreme vertices design and simultaneous optimization technique.
    Hirata M; Takayama K; Nagai T
    Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):741-6. PubMed ID: 1611687
    [No Abstract]   [Full Text] [Related]  

  • 14. [Release of diltiazem chloride and ibuprofen from hydrophilic matrix tablets].
    Vostalová L; Rabisková M; Medvecká G
    Ceska Slov Farm; 2003 Nov; 52(6):295-8. PubMed ID: 14661369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained delivery of captopril from floating matrix tablets.
    Jiménez-Martínez I; Quirino-Barreda T; Villafuerte-Robles L
    Int J Pharm; 2008 Oct; 362(1-2):37-43. PubMed ID: 18588962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.
    Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P
    Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New co-polymer zwitterionic matrices for sustained release of verapamil hydrochloride.
    Kostova B; Rachev D
    Acta Pharm; 2007 Dec; 57(4):429-39. PubMed ID: 18165187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citric acid as a solid-state plasticizer for Eudragit RS PO.
    Schilling SU; Shah NH; Malick AW; Infeld MH; McGinity JW
    J Pharm Pharmacol; 2007 Nov; 59(11):1493-500. PubMed ID: 17976259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets.
    Li FQ; Hu JH; Deng JX; Su H; Xu S; Liu JY
    Int J Pharm; 2006 Nov; 324(2):152-7. PubMed ID: 16837152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of sodium alginate as drug release modifier in matrix tablets.
    Liew CV; Chan LW; Ching AL; Heng PW
    Int J Pharm; 2006 Feb; 309(1-2):25-37. PubMed ID: 16364576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.